{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:24:29Z","timestamp":1787131469428,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijmmb.2026.101154","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:45:14Z","timestamp":1779428714000},"page":"101154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In-vitro evaluation of Cefiderocol and Ceftazidime\/Avibactam against MDR and XDR gram-negative pathogens from clinical isolates, with whole genome sequencing-based analysis of Antimicrobial Resistance Genes in Cefiderocol-resistant Escherichia coli"],"prefix":"10.1016","volume":"62","author":[{"given":"Kalaivani","family":"Ramakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Kali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1726-7142","authenticated-orcid":false,"given":"Ramasamy","family":"Dhamodharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijmmb.2026.101154_bib1","first-page":"438","article-title":"Severe infections caused by difficult-to-treat Gram-negative bacteria","volume":"29","author":"Dettori","year":"2023","journal-title":"Curr Opin Crit Care"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101154_bib2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.18203\/2320-6012.ijrms20181288","article-title":"Prevalence of extended spectrum \u03b2-lactamase, AmpC \u03b2-lactamase and metallo \u03b2-lactamase mediated resistance in Escherichia coli from diagnostic and tertiary healthcare centers in south Bangalore, India","volume":"6","author":"Tewari","year":"2018","journal-title":"Int J Res Med Sci"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101154_bib3","first-page":"1069","article-title":"The demise of the antibiotic pipeline: the bayer case","volume":"11","author":"Skender","year":"2024","journal-title":"Hum Soc Sci Commun"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101154_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/2589977513666211206100749","article-title":"Cefiderocol: a new antimicrobial for complicated urinary tract infection (CUTI) caused by Carbapenem-resistant enterobacteriaceae (CRE)","volume":"14","author":"Chatterjee","year":"2022","journal-title":"Curr Drug Res Rev"},{"issue":"30","key":"10.1016\/j.ijmmb.2026.101154_bib5","doi-asserted-by":"crossref","first-page":"21328","DOI":"10.1039\/D4RA04302B","article-title":"Cefiderocol susceptibility endows hope in treating carbapenem-resistant Pseudomonas aeruginosa: insights from in vitro and in silico evidence","volume":"14","author":"Basu","year":"2024","journal-title":"RSC Adv"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101154_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12098-022-04468-7","article-title":"Cefiderocol as salvage therapy for carbapenem-resistant Klebsiella pneumoniae sepsis in an extremely preterm neonate","volume":"90","author":"Bawankule","year":"2023","journal-title":"Indian J Pediatr"},{"issue":"5","key":"10.1016\/j.ijmmb.2026.101154_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00847-23","article-title":"In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam\/aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India","volume":"11","author":"Borde","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijmmb.2026.101154_bib8","series-title":"Guidance on diagnosis & management of Carbapenem Resistant Gram-negative infections. New Delhi: Division of Epidemiology & Communicable Diseases","first-page":"23","year":"2022"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101154_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijmmb.2026.101154_bib10","first-page":"35","volume":"M100","year":"2025"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101154_bib11","first-page":"1212","article-title":"Prevalence of multi drug resistant and extensively drug resistant in Gram negative bacterial isolates from different clinical samples","volume":"14","author":"Rani","year":"2025","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101154_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/pathogens14040307","article-title":"New \u03b2-Lactam\/\u03b2-Lactamase inhibitor combination antibiotics","volume":"14","author":"Sargianou","year":"2025","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.ijmmb.2026.101154_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.cmi.2019.03.030","article-title":"Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae in different groups of patients","volume":"25","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.ijmmb.2026.101154_bib14","article-title":"Early and appropriate use of ceftazidime-avibactam in the management of multidrug-resistant gram-negative bacterial infections in the Indian scenario","volume":"14","author":"Swaminathan","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101154_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13756-025-01518-5","article-title":"Global trends of ceftazidime-avibactam resistance in gram-negative bacteria: systematic review and meta-analysis","volume":"14","author":"Wang","year":"2025","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijmmb.2026.101154_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2024.100622","article-title":"In-vitro approaches for cefiderocol susceptibility testing and interpretation in the context of recent clinical & laboratory standards institute advisory","volume":"50","author":"Bakthavatchalam","year":"2024","journal-title":"Indian J Med Microbiol"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101154_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12941-023-00573-3","article-title":"Ceftazidime-avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope","volume":"22","author":"Taha","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101154_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.117216","article-title":"Evaluation of aztreonam\/avibactam gradient test strip and aztreonam-ceftazidime\/avibactam broth disk elution method for susceptibility testing of metallo-\u03b2-lactamase positive carbapenemase-producing bacteria","volume":"114","author":"Hamze","year":"2026","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101154_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-026-05406-7","article-title":"Aztreonam plus ceftazidime\/avibactam broth disk elution test: failure to detect Escherichia coli with PBP-3 insertions","author":"Peirano","year":"2026","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.ijmmb.2026.101154_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/23744235.2020.1788224","article-title":"Phenotypic synergy testing of ceftazidime\u2013avibactam with aztreonam in a university hospital having high number of metallobetalactamase producing bacteria","volume":"52","author":"Sahu","year":"2020","journal-title":"Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101154_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2025.100793","article-title":"In-vitro susceptibility of cefiderocol and other comparators in carbapenem-resistant Gram-negative bacilli: a study from India","volume":"54","author":"Didwania","year":"2025","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2026.101154_bib22","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.2147\/IDR.S378579","article-title":"Analysis of in vitro activity of cefiderocol against carbapenem-resistant gram-negative Bacilli by broth microdilution and disk diffusion method: a single-center study in Odisha, India","volume":"15","author":"Nayak","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijmmb.2026.101154_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2024.100556","article-title":"In vitro activity of the newly approved antimicrobial agent cefiderocol against carbapenem resistant gram negative clinical isolates","volume":"48","author":"Khanchandani","year":"2024","journal-title":"Indian J Med Microbiol"},{"issue":"6","key":"10.1016\/j.ijmmb.2026.101154_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"10.1016\/j.ijmmb.2026.101154_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad276","article-title":"An NDM-producing Escherichia coli clinical isolate exhibiting resistance to cefiderocol and the combination of ceftazidime-avibactam and aztreonam: another step toward Pan-\u03b2-Lactam resistance","volume":"10","author":"Simner","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101154_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02670-21","article-title":"Occurrence of high levels of cefiderocol resistance in carbapenem-resistant Escherichia coli before its approval in China: a report from China CRE-network","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijmmb.2026.101154_bib27","article-title":"Whole-genome sequence analysis of cefiderocol-resistant E. coli and Klebsiella pneumoniae isolates from cefiderocol treatment-na\u00efve patients","volume":"59","author":"Nayak","year":"2025","journal-title":"Indian J Med Microbiol"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S025508572600112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S025508572600112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:29:37Z","timestamp":1787128177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S025508572600112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S025508572600112X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101154","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro evaluation of Cefiderocol and Ceftazidime\/Avibactam against MDR and XDR gram-negative pathogens from clinical isolates, with whole genome sequencing-based analysis of Antimicrobial Resistance Genes in Cefiderocol-resistant Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101154"}}